Impact of HMGB1 on Diastolic Dysfunction in Hypertensive Patients
NCT03177408 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2017-06-06
Summary
This study evaluated the association between HMGB1 and diastolic dysfunction in hypertensive patients. HMGB1 level were tested in all patients, and diastolic function determined by echocardiographic.
Conditions
- Diastolic Dysfunction
- Hypertension
- Inflammation
Sponsors & Collaborators
-
Jing Li
lead OTHER
Eligibility
- Min Age
- 30 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-08-15
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
More Related Trials
-
Acute Effect of Agiotensin-(1-7) in Healthy and Hypertensive Subjects
NCT03001271 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Genetic Architecture of Natriuretic Peptides and Blood Pressure Response
NCT07118592 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Multi-center Study on New Cardiovascular Remodeling and Function Parameters in Hypertension
NCT05638503 ·Status: RECRUITING
-
Mechanisms Underlying Abnormal Ambulatory BP Patterns
NCT00005346 ·Status: COMPLETED
-
Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression
NCT00518479 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Follow-up Study in Two Chinese Hypertension Cohorts
NCT04471389 ·Status: UNKNOWN
-
Renal Sympathetic Denervation in Patients With Drug-resistant Hypertension and Symptomatic Atrial Fibrillation
NCT01713270 ·Status: UNKNOWN ·Phase: NA
-
Predictive Factors of Systolic Dysfunction in Non-complicated Hypertensive Patients
NCT02841696 ·Status: COMPLETED
-
Role of Endothelin in the Regulation of Vascular Tone in Patients With Essential Hypertension
NCT00001527 ·Status: COMPLETED
-
Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level
NCT03990480 ·Status: COMPLETED ·Phase: PHASE4
-
Prognostic Value of Plasma Biomarkers Among Patients With Hypertension
NCT04107584 ·Status: UNKNOWN
-
White Coat Hypertension and Antihypertensive Treatment Effect - SCOR in Hypertension
NCT00005316 ·Status: COMPLETED
-
Renal Sympathetic Modification in Patients With Essential Hypertension
NCT01417221 ·Status: UNKNOWN ·Phase: NA
-
Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension
NCT03592667 ·Status: UNKNOWN ·Phase: PHASE4
-
Nocturnal Blood Pressure Dipping and Ventricular Repolarization in Hypertension
NCT07200856 ·Status: NOT_YET_RECRUITING
-
Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular Health
NCT02330224 ·Status: COMPLETED ·Phase: NA
-
HaemoDYNAMICs in Primary and Secondary Hypertension
NCT01742702 ·Status: RECRUITING
-
Natriuretic Peptide System as Therapy in Human Preclinical Left Ventricle Dysfunction
NCT00387621 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dietary Sodium's Effect on Urinary Sodium and Dopamine Excretion in Patients With Postural Tachycardia Syndrome
NCT01563107 ·Status: COMPLETED ·Phase: NA
-
Blood Pressure and Diurnal Variation in Sodium, Potassium, and Water Excretion
NCT00005204 ·Status: COMPLETED
-
Short Term Effect of Empagliflozin in Hypertension
NCT04203914 ·Status: COMPLETED ·Phase: PHASE4
-
Adolescent Blood Pressure Variation and Ventricular Mass
NCT00005200 ·Status: COMPLETED
-
Prevalence of Primary Aldosteronism in Patients With Resistant Hypertension in China
NCT01459042 ·Status: COMPLETED
-
Long-term of Remote Ischemic Preconditioning and Mindfulness in Patients With Mild Hypertension
NCT04753840 ·Status: RECRUITING ·Phase: NA
-
Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular Health
NCT02972619 ·Status: UNKNOWN ·Phase: NA